Rethinking Trial Design for Market Access: Aligning R&D With HTA And IRA Demands For Strong Post Market Outcomes

Name: Rethinking Trial Design for Market Access: Aligning R&D With HTA And IRA Demands For Strong Post Market Outcomes
Start: 2027-09-15T15:10
End: 2027-09-15
Location: Hynes Convention Center

World Evidence, Pricing and Access Congress USA · 15 September 2027 · 15:10

Rethinking Trial Design for Market Access: Aligning R&D With HTA And IRA Demands For Strong Post Market Outcomes was a session at World Evidence, Pricing and Access Congress USA on 15 September 2027 in Boston, with 2 speakers on record.

Speakers

Alan Balch — Speaker Executive Chair, Patient Advocate Foundation
Ipek Ozer Stillman — Speaker Head, Global Health Economics, Payer Value & Patient Access, Takeda